» Articles » PMID: 1929892

Improved Recognition of Leukoaraiosis and Cognitive Impairment in Alzheimer's Disease

Overview
Journal Arch Neurol
Specialty Neurology
Date 1991 Oct 1
PMID 1929892
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

We identified 85 patients in a longitudinal study of dementia who had uncomplicated Alzheimer's disease and in whom computed tomography of the head and psychometric testing were conducted within a 6-month period following their entry into the study. Thirty-four patients (40%) had leukoaraiosis, which was disproportionately common in female patients (62% vs 15% in male patients). Analysis of covariance demonstrated a relative reduction of scores on the Extended Scale for Dementia in those patients who had leukoaraiosis, after adjusting for the confounding effects of age, sex, educational level, and duration of illness. Leukoaraiosis was also much more common in women, even after adjusting for the possible confounding effects of age, duration of illness, Extended Scale for Dementia score, and hypertension. Multiple regression analysis showed that leukoaraiosis accounted for 11.6% of the variance of the Extended Scale for Dementia scores. Leukoaraiosis, together with duration of illness, accounted for 18.2% of the variance. Leukoaraiosis is associated with a greater degree of cognitive impairment in patients with Alzheimer's disease.

Citing Articles

Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer's Disease.

Obis E, Sol J, Andres-Benito P, Martin-Gari M, Mota-Martorell N, Galo-Licona J Aging Dis. 2023; 14(5):1887-1916.

PMID: 37196109 PMC: 10529741. DOI: 10.14336/AD.2023.0217.


A History of Senile Plaques: From Alzheimer to Amyloid Imaging.

Beach T J Neuropathol Exp Neurol. 2022; 81(6):387-413.

PMID: 35595841 PMC: 9122832. DOI: 10.1093/jnen/nlac030.


Cerebral Small Vessel Disease.

Litak J, Mazurek M, Kulesza B, Szmygin P, Litak J, Kamieniak P Int J Mol Sci. 2021; 21(24).

PMID: 33419271 PMC: 7766314. DOI: 10.3390/ijms21249729.


White matter alterations in Alzheimer's disease without concomitant pathologies.

Ferrer I, Andres-Benito P Neuropathol Appl Neurobiol. 2020; 46(7):654-672.

PMID: 32255227 PMC: 7754505. DOI: 10.1111/nan.12618.


Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease.

Levit A, Hachinski V, Whitehead S Geroscience. 2020; 42(2):445-465.

PMID: 32002785 PMC: 7205943. DOI: 10.1007/s11357-020-00164-6.